General Information of the m6A Target Gene (ID: M6ATAR00427)
Target Name Transferrin receptor protein 1 (TFRC)
Gene Name TFRC
Chromosomal Location 3q29
Family peptidase M28 family; M28B subfamily
Function
Cellular uptake of iron occurs via receptor-mediated endocytosis of ligand-occupied transferrin receptor into specialized endosomes. Endosomal acidification leads to iron release. The apotransferrin-receptor complex is then recycled to the cell surface with a return to neutral pH and the concomitant loss of affinity of apotransferrin for its receptor. Transferrin receptor is necessary for development of erythrocytes and the nervous system (By similarity). A second ligand, the heditary hemochromatosis protein HFE, competes for binding with transferrin for an overlapping C-terminal binding site. Positively regulates T and B cell proliferation through iron uptake. Acts as a lipid sensor that regulates mitochondrial fusion by regulating activation of the JNK pathway. When dietary levels of stearate (C18:0) are low, promotes activation of the JNK pathway, resulting in HUWE1-mediated ubiquitination and subsequent degradation of the mitofusin MFN2 and inhibition of mitochondrial fusion. When dietary levels of stearate (C18:0) are high, TFRC stearoylation inhibits activation of the JNK pathway and thus degradation of the mitofusin MFN2; (Microbial infection) Acts as a receptor for new-world arenaviruses: Guanarito, Junin and Machupo virus.
    Click to Show/Hide
Gene ID 7037
Uniprot ID
TFR1_HUMAN
HGNC ID
HGNC:11763
Ensembl Gene ID
ENSG00000072274
KEGG ID
hsa:7037
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
TFRC can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
RNA demethylase ALKBH5 (ALKBH5) [ERASER]
Representative RNA-seq result indicating the expression of this target gene regulated by ALKBH5
Cell Line Neutrophils Mus musculus
Treatment: Alkbh5-/- neutrophils
Control: Wild type neutrophils
GSE198316
Regulation
logFC: -1.41E+00
p-value: 1.41E-09
More Results Click to View More RNA-seq Results
In total 1 item(s) under this regulator
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene [1]
Response Summary IOX1, which is an inhibitor of ALKBH5, was loaded on HSSS to form HSSS-I, which could effectively ameliorate cardiac dysfunction in acute myocardial infarction. The surface-modified bioengineered ferritin nanocage targeted the dying cells in the infarct area under the guidance of Scarf1. These cells were then phagocytosed through recognition of their Transferrin receptor protein 1 (TFRC) receptor.
Responsed Disease Acute myocardial infarction ICD-11: BA41
Cell Process Lysosomal escape
In-vivo Model Wild-type C57 (female, 12-16 weeks old), ALKBH5 /- mice (female and male, 12-16 weeks old), and SPF-grade SD rats (female, 180-230 g) were used to establish the AMI model.Sodium pentobarbital diluted to 10 mg/mL was used to anesthetize the mice or rat at the dose of 50 mg/kg through an intraperitoneal injection. By using a small animal ventilator with endotracheal intubation, thoracotomy was performed at the left fourth intercostal region. The heart was exposed, and the left anterior descending coronary artery (LCA) was occluded through a 6-0 silk suture that was placed 2-3 mm distal to the origin of the LCA with a slipknot. The apical region turned white, and ST segment elevation and T wave inversion of ECG showed that the AMI model was successfully established. Forty-five minutes after ischemia, the slipknot was released, and the ischemic region was reperfused. PBS (0.2 ml), HSSS (23.5 mg/kg, 0.2 ml), IOX1 (10 mg/kg, 0.2 ml), and HSSS-I (33.5 mg/kg, containing 10 mg/kg IOX1, 0.2 ml) were administered through caudal vein injection for 14 days at the frequency of one time per day.
YTH domain-containing family protein 1 (YTHDF1) [READER]
Representative RIP-seq result supporting the interaction between TFRC and the regulator
Cell Line Hela Homo sapiens
Regulation logFC: 2.40E+00 GSE63591
In total 1 item(s) under this regulator
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene [2]
Response Summary YTHDF1 enhanced Transferrin receptor protein 1 (TFRC) expression in HPSCC through an m6A-dependent mechanism.
Target Regulation Up regulation
Responsed Disease Hypopharyngeal squamous cell carcinoma ICD-11: 2B6D.0
Pathway Response Ferroptosis hsa04216
Cell Process Ferroptosis
In-vitro Model YCU-MS861 Maxillary sinus squamous cell carcinoma Homo sapiens CVCL_8021
YCU-MS861 Maxillary sinus squamous cell carcinoma Homo sapiens CVCL_8021
FaDu Hypopharyngeal squamous cell carcinoma Homo sapiens CVCL_1218
Detroit 562 Pharyngeal squamous cell carcinoma Homo sapiens CVCL_1171
Hypopharyngeal cancer [ICD-11: 2B6D]
In total 1 item(s) under this disease
Experiment 1 Reporting the m6A-centered Disease Response [2]
Response Summary YTHDF1 enhanced Transferrin receptor protein 1 (TFRC) expression in HPSCC through an m6A-dependent mechanism.
Responsed Disease Hypopharyngeal squamous cell carcinoma [ICD-11: 2B6D.0]
Target Regulator YTH domain-containing family protein 1 (YTHDF1) READER
Target Regulation Up regulation
Pathway Response Ferroptosis hsa04216
Cell Process Ferroptosis
In-vitro Model YCU-MS861 Maxillary sinus squamous cell carcinoma Homo sapiens CVCL_8021
YCU-MS861 Maxillary sinus squamous cell carcinoma Homo sapiens CVCL_8021
FaDu Hypopharyngeal squamous cell carcinoma Homo sapiens CVCL_1218
Detroit 562 Pharyngeal squamous cell carcinoma Homo sapiens CVCL_1171
Acute myocardial infarction [ICD-11: BA41]
In total 1 item(s) under this disease
Experiment 1 Reporting the m6A-centered Disease Response [1]
Response Summary IOX1, which is an inhibitor of ALKBH5, was loaded on HSSS to form HSSS-I, which could effectively ameliorate cardiac dysfunction in acute myocardial infarction. The surface-modified bioengineered ferritin nanocage targeted the dying cells in the infarct area under the guidance of Scarf1. These cells were then phagocytosed through recognition of their Transferrin receptor protein 1 (TFRC) receptor.
Responsed Disease Acute myocardial infarction [ICD-11: BA41]
Target Regulator RNA demethylase ALKBH5 (ALKBH5) ERASER
Cell Process Lysosomal escape
In-vivo Model Wild-type C57 (female, 12-16 weeks old), ALKBH5 /- mice (female and male, 12-16 weeks old), and SPF-grade SD rats (female, 180-230 g) were used to establish the AMI model.Sodium pentobarbital diluted to 10 mg/mL was used to anesthetize the mice or rat at the dose of 50 mg/kg through an intraperitoneal injection. By using a small animal ventilator with endotracheal intubation, thoracotomy was performed at the left fourth intercostal region. The heart was exposed, and the left anterior descending coronary artery (LCA) was occluded through a 6-0 silk suture that was placed 2-3 mm distal to the origin of the LCA with a slipknot. The apical region turned white, and ST segment elevation and T wave inversion of ECG showed that the AMI model was successfully established. Forty-five minutes after ischemia, the slipknot was released, and the ischemic region was reperfused. PBS (0.2 ml), HSSS (23.5 mg/kg, 0.2 ml), IOX1 (10 mg/kg, 0.2 ml), and HSSS-I (33.5 mg/kg, containing 10 mg/kg IOX1, 0.2 ml) were administered through caudal vein injection for 14 days at the frequency of one time per day.
References
Ref 1 Amelioration of acute myocardial infarction injury through targeted ferritin nanocages loaded with an ALKBH5 inhibitor. Acta Biomater. 2022 Mar 1;140:481-491. doi: 10.1016/j.actbio.2021.11.041. Epub 2021 Dec 5.
Ref 2 YTHDF1-enhanced iron metabolism depends on TFRC m(6)A methylation. Theranostics. 2020 Oct 26;10(26):12072-12089. doi: 10.7150/thno.51231. eCollection 2020.